RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation

Area of Science:

• Molecular Biology
• Immunology
• Cell Signaling

Background:

• Inflammation is a critical host defense mechanism against damage and infection.
• Protein kinases are key regulators of inflammatory signaling and potential therapeutic targets.
• The RSK (Ribosomal S6 Kinase) family plays diverse roles in cellular processes.

Purpose of the Study:

• To investigate the role of RSK2 in inflammation signaling.
• To elucidate the interaction between RSK2 and TRAF6 (TNF receptor-associated factor 6).
• To determine RSK2's function in TRAF6 ubiquitination and subsequent inflammatory responses.

Main Methods:

• In vitro kinase assays to assess RSK2 phosphorylation of TRAF6.
• Cellular experiments involving TRAF6 overexpression and RSK2 knockdown.
• Analysis of TRAF6 K63 ubiquitination.
• In vivo studies using RSK2 wild-type and knockout mouse models of colon inflammation.
• Measurement of immune cell infiltration and inflammatory signaling pathway activation.

Main Results:

• RSK2 directly phosphorylates TRAF6 at serines 46, 47, and 48.
• RSK2 positively regulates TRAF6 K63 ubiquitination, a process also dependent on TRAF6.
• RSK2 knockout mice exhibited reduced F4/80 and CD3 immune cell infiltration in a colon inflammation model.
• Inflammatory signaling pathways (Ikkα/β, p38, JNKs) were significantly downregulated in RSK2 knockout mice.

Conclusions:

• RSK2 acts as a crucial mediator in inflammation signaling.
• Phosphorylation of TRAF6 by RSK2 is essential for TRAF6 K63 ubiquitination.
• This RSK2-TRAF6 interaction is critical for the induction of inflammatory responses and cytokine production.